¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sequence feedback inhibition"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® feedback ÇÑ±Û µÇ¸ÔÀÓ
¼³¸í   
  ÀԷ°ú Ãâ·ÂÀ» °®Ãá Á¦¾î½Ã½ºÅÛ¿¡¼­ Ãâ·ÂÀÇ ÀϺθ¦ ÀÔ·ÂÃøÀ¸·Î µÇµ¹·Á ÀÔ·ÂÀ¸·Î »ç¿ëÇϴ ÀÏ. ÁõÆø±â³ª ÀÚµ¿ Á¦¾î µûÀ§ÀÇ Àü±âȸ·Î¿¡ ¸¹ÀÌ »ç¿ëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • feedback
    µÇ¸ÔÀÓ
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • positive feedback
    ¾ç¼ºµÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¿¬¼â, ¼±Á¾¾ÏÁ¾¿¬¼â
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
  • intervening sequence
    °³Àç¼ø¼­
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼ÒÁõ¿¬¼â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀÓ
  • sequence
    ¼ø¼­, ¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
  • inhibition
    ¾ïÁ¦, ÀúÁö
  • competitive inhibition
    °æÀï¾ïÁ¦
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦, »óÈ£¾ïÁ¦
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • inhibition test
    ¾ïÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀÓ±âÀü
  • feedback circuit
    µÇ¸ÔÀÓȸ·Î
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀÓ
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • regulatory motor feedback
    ¿îµ¿Á¶ÀýµÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¿ä¼¼°ü»ç±¸Ã¼µÇ¸ÔÀÓ, ¿ä¼¼°üÅ丮µÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¼ø¼­
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüǪ¸®¾îº¯È¯¿¬¼â
  • echo train sequence
    ¿¡ÄÚ¿­¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ±â¿ï±âȸº¹¿¬¼â
  • flow compensated pulse sequence
    È帧º¸»óÆÞ½º¿¬¼â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Long-loop feedback
    Àåȯ(íóü») µÇ¸ÔÀ̱â
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • Carr Purcell sequence Carr Pursell
    ¿¬¼â
  • DNA sequence analysis
    DNA ¼­¿­ºÐ¼®
  • FID pulse sequence
    ÀÚÀ¯ ºØ±« À¯µµ ÆÞ½º ¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • insertion sequence, IS
    »ðÀÔ¼­¿­, »ðÀÔ¿ä¼Ò
  • porters sequence
    Æ÷ÅÍ¿¬¼â(¡­ææáð), Æ÷Å͹迭¼ø(¡­ÛÕÖªâ÷)
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    µÇ¸ÔÀÓ¾ïÁ¦(åäð¤).
  • negative feedback inhibition
    À½¼ºµÇ¸ÔÀÓ¾ïÁ¦.
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ(Ë´Ì·).
  • feedback circuit
    µÇ¸ÔÀ̱âȸ·Î(üÞÖØ), µÇ¸ÔÀÓȸ·Î (¡­üÞÖØ).
  • informational feedback
    Á¤º¸ µÇ¸ÔÀÓ
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü.
  • test, delayed feedback
    Áö¿¬Àç»ý°Ë»ç
  • tubuloglomerular feedback
    ¼¼´¢°ü»ç±¸Ã¼ µÇ¸ÔÀÓ
  • tubuloglomerular feedback
    ¼¼´¢°ü »ç±¸Ã¼ µÇ¸ÔÀ̱â
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • breech disruption sequence
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sequence feedback inhibition
    ¼­¿­(ßíÖª) µÇ¸ÔÀÓÀúÇØ(îÁúª)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • concerted feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • cooperative feedback inhibition
    Çùµ¿(úðÔÒ) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • cumulative feedback inhibition
    ´©Àû(׫îÝ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • enzyme multiplicity feedback inhibition
    È¿¼Ò ´Ù¾ç¼º(ý£áÈÒýåÆàõ) µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • feedback inhibition
    µÇ¸ÔÀÓ ÀúÇØ(îÁúª)
  • multivalent feedback inhibition
    ´Ù°¡(Òýʤ) µÇ¸ÔÀÓÀúÇØ(îÁúª)
  • bifunctional feedback
    ¾ç±â´É(å»Ñ¦Òö) µÇ¸ÔÀÓ
  • feedback
    µÇ¸ÔÀÓ
  • feedback deletion hypothesis
    µÇ¸ÔÀÓ °á¼Õ¼³(ÌÀáßàã)
  • feedback loop
    µÇ¸ÔÀÓ ·çÇÁ
  • feedback repression
    µÇ¸ÔÀÓ ¾ïÁ¦(åäð¤)
  • negative feedback
    À½¼º(ëäàõ)µÇ¸ÔÀÓ
  • positive feedback
    "°¡(ʦ)µÇ¸ÔÀÓ, ¾ç¼º(åÕàõ)µÇ¸ÔÀÓ"
  • unifunctional feedback
    ´Ü±â´É(ӤѦÒö) µÇ¸ÔÀ̱â
  • Alu sequence
    Alu ¼­¿­(ßíæê)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • inhibition
    ¾ïÁ¦, ÀúÁö, ÀúÇØ
  • Carr Purcell sequence
    Carr Pursell¿¬¼â
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüFourierº¯È¯¿¬¼â
  • echo train sequence
    ¿¡ÄÚ¿­¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ°æ»çȸº¹¿¬¼â
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • FID pulse sequence
    ÀÚÀ¯ºØ±«À¯µµÆÞ½º¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿º¸»óÆÞ½º¿¬¼â
  • flow sensitive gradient echo sequence
    À¯µ¿¹Î°¨°æ»ç¿¡ÄÚ¿¬¼â
  • gradient echo [=GRE] pulse sequence
    °æ»ç¿¡ÄÚÆÞ½º¿¬¼â
  • gradient echo sequence
    °æ»ç¿¡ÄÚ¿¬¼â
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging sequence
    ¿µ»ó¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RI radiation intensity; radioactive isotope; radioimmunology; recession index; recombinant inbred [stra...
FIF feedback inhibition factor; fibroblast interferon; forced inspiratory flow; formaldehyde-induced flu...
IS ileal segment; immediate sensitivity; immune serum; immunosuppression; impingement syndrome; incenti...
RSI rapid-sequence induction; rapid sequence intubation; repetition strain injury
EIC elastase inhibition capacity; enzyme inhibition complex
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DAF Delayed Auditory Feedback
TGF Tubuloglomerular feedback
ACEi Angiotensin I converting enzyme inhibition
BIS Behavioral Inhibition System
CEI Converting enzyme inhibition
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • negative feedback inhibition
    À½¼º µÇ¸ÔÀ̱⠾ïÁ¦
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â
  • Carr Purcell sequence
    Carr Pursell ¿¬¼â
  • developmental sequence
    ¹ß´Þ ¼ø¼­
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿ º¸»ó ÆÞ½º ¿¬¼â
  • Fourier acquisition in the steady state sequence
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • auditory feedback
    û°¢ Çǵå¹é, û°¢Àû µÇ¸ÔÀÓ
  • delayed feedback test
    Áö¿¬ Àç»ý °Ë»ç
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ, µÇ¸ÔÀÓ, Çǵå¹é
    ¾î¶² °úÁ¤À» Á¦¾îÇϱâ À§ÇÏ¿© Ãâ·ÂÀÇ ¾î¶² ºÎºÐÀ» ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â °Í.
  • feedback circuit
    µÇ¸ÔÀ̱â ȸ·Î, µÇ¸ÔÀÓ È¸·Î
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
feedback inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
positive feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
negative feedback This occurs where the products of a process can act at an earlier stage in the process to inhibit their own formation. The term was first used widely in conjunction with electrical amplifiers where negative feedback was applied to limit distortion of the signal by the amplification mechanism. Tends to stabilise the process. In contrast to positive feedback.
(18 Nov 1997)
feedback <physiology> The return of some of the output of a system as input so as to exert some control in the process.
(18 Nov 1997)
feedback activation The activation of an enzyme by an end product of a biochemical pathway in which that enzyme plays a part. For example, the activation of factors VIII and V by thrombin during blood clotting.
(05 Mar 2000)
feedback control The regulation of the activity of an enzyme by one of its products.
(09 Oct 1997)
feedback regulation <physiology> Control mechanism that uses the consequences of a process to regulate the rate at which the process occurs: if, for example: the products of a reaction inhibit the reaction from proceeding (or slow down the rate of the reaction), then there is negative feedback, something that is very common in metabolic pathways.
Positive feedback is liable to lead to exponential increase and may be explosively dangerous in some cases.
Other examples are the action of voltage dependent sodium channels in generating action potentials and the activation of blood clotting factors V and VIII by thrombin. Without damping, feedback can lead to resonance (hunting) and oscillation in the system.
(18 Nov 1997)
feedback system A complex of neuronal circuits whereby a part of the efferent path returns to the input to modulate its activity, thus acting as a governor on the system.
See: feedback.
(05 Mar 2000)
allogeneic inhibition Inhibition or injury to allogeneic cells that occurs when lymphocytes are mixed and cultured with other cells of different genotypes in vitro.
(05 Mar 2000)
macrophage inhibition factor <cytokine> A group of lymphokines (including a 14 kD glycoprotein) produced by activated T lymphocytes that reduces macrophage mobility and probably increases macrophage macrophage adhesion.
(18 Nov 1997)
macrophage migration inhibition test A test which measures the presence of migration-inhibitory factor. Usually peritoneal macrophages are placed in a capillary tube in the presence or absence of supernatants from activated T-cells. If MIF is present, the migration of monocyte/macrophages is reduced.
Synonym: macrophage migration inhibition test, migration inhibition test.
(05 Mar 2000)
reactive inhibition Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.
(12 Dec 1998)
reciprocal inhibition Contraction in a muscle is accompanied by a loss of tone or by relaxation in the antagonistic muscle.
Synonym: reciprocal inhibition.
(05 Mar 2000)
reflex inhibition A situation in which sensory stimuli decrease reflex activity.
(05 Mar 2000)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • feedback inhibition
    Çǵå¹é ÀúÇØ
  • inhibition
    ¾ïÁ¦
  • inhibition
    ±ÝÁö;±ÝÁ¦;¾ïÁ¦;¾ï¾Ð;(¿µ±¹±³)¼º¹«ÁýÇà±ÝÁö¸í·É;(¿µ¹ý)¼Ò¼ÛÁøÇàÁ¤Áö¿µÀå
  • sequence
    °è¼ÓÇϱâ
  • feedback
    Çǵå¹é(Ãâ·Â¿¡³ÊÁöÀÇ ÀϺθ¦ ÀÔ·ÂÀ¸·Î µÇµ¹¸®´Â Á¶ÀÛ);Á¾ÇÕÀÛ¿ë;¹ÝÇâ;Çǵå¹éÀÇ;Àç»ýÀÇ
  • insertion sequence
    »ðÀԹ迭
  • negative feedback
    À½ µÇ¸ÔÀÓ;À½ Çǵå¹é
  • nucleotide sequence
    (»ýÈ­)´ºÅ¬·¹¿ÀƼµå ¹è¿­
  • regenerative feedback
    Àç»ý Çǵå¹é(ÀÔ·Â À§»ó¿¡ ¸ÂÃß¾î µÇµ¹·Á º¸³»´Â)
  • sequence
    ¿¬¼Ó;¼ø¼­;Â÷·Ê;°á°ú;¼ø¼­·Î µÈ µ¿Á¾ÀÇ ÆÐÀÇ ÇÑ Á¶;±Í°á;°á°ú;ÀÕ´Ü;ÀÕ´Þ¾Æ ÀϾ´Â;ÇÊ¿¬ÀûÀÎ °á°ú·Î¼­ ÀϾ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á